Value Health to sell Lewin-VHI consulting due to alleged conflict of interest.
Executive Summary
VALUE HEALTH TO SELL LEWIN CONSULTING DUE TO "ALLEGED CONFLICT of interest problems with Value Health's core businesses," Value Health announced July 31. The announcement came after two contracts awarded to Value Behavioral Health were challenged by losing bidders on the grounds that Lewin-VHI had been involved in consulting with the contractor. Value Health stressed that it considers the conflict of interest allegations to be "specious."
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth